What is Alzheimer's Disease?
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases, and its incidence increases rapidly with age. With the intensification of societal aging, this disease may bring about increasingly severe social burdens.
In individuals affected by Alzheimer's, the aggregation of these toxic proteins leads to the formation of plaques and tangles within the brain. These abnormal structures disrupt neural communication, induce cellular damage, and subsequently result in cognitive decline and memory impairment, hallmarks of the disease.
ALZHIMER’S HAS NO CURE
Globally, there is a new dementia patient every 3 seconds. With the exacerbation of aging population, the number of Alzheimer's patients is increasing. It is estimated that by 2050, the number of Alzheimer's dementia patients in Asia will reach 25 million, meaning there will be 2 Alzheimer's patients among every 100 individuals. Alzheimer's disease also exhibits a trend toward younger onset. Data released as early as 2015 indicated that the onset age of dementia has shifted from the formerly recognized age of 65 to 55.
Currently, only six drugs have received FDA approval for market use globally: Tacrine approved in 1993, Donepezil in 1996, Rivastigmine in 2000, Galantamine in 2001, Memantine hydrochloride in 2003, and Memantine in 2014. However, all these drugs are symptomatic treatments, and none can treat Alzheimer's disease itself. Therefore, after being diagnosed with AD, there is no cure or reversal from drug intake as of now. All we can do is, based on existing research, try to prevent ourselves from falling prey to this gentle but fatal illness.
Currently, only six drugs have received FDA approval for market use globally: Tacrine approved in 1993, Donepezil in 1996, Rivastigmine in 2000, Galantamine in 2001, Memantine hydrochloride in 2003, and Memantine in 2014. However, all these drugs are symptomatic treatments, and none can treat Alzheimer's disease itself. Therefore, after being diagnosed with AD, there is no cure or reversal. All we can do is, based on existing research, try to prevent ourselves from falling prey to this gentle but fatal illness.
REWIRING THE BRAIN- THE NEXT FRONTIER OF SUPERMIRCOSURGERY-a PRS REVIEW
Dr. Qingping Xie:
Inventor and expert on Deep cervical LVA supermicrosurgery method for AD disease
Prof. QINGPING XIE is an expert microsurgeon at Hangzhou qiushi hosptial Hangzhou, China. He obtained his MD from the Second Military Medical University in Shanghai in 1989 and formerly served as the Director of the Hand Surgery Department, Peripheral Nerve Diagnostic and Therapeutic Center, Sino-Japanese Artificial Finger Joint Transplantation Training Center, and the International Rheumatoid Arthritis Joint Diagnosis and Treatment Center at Zhejiang People's Hospital. Presently, he holds the positions of President at Hangzhou Qiushi Hospital, President at Hangzhou Huagong Hospital, and Honorary President at Hangzhou Plastic Surgery Hospital.
Previously serving as chief director on Orthopedic department in Zhejiang People’s provincial Hospital specializing on the microsurgical procedures for finger joint implants and vessel reconstruction. Various esteemed positions held by Prof Qingping Xie in different medical associations and academic groups:
-
Visiting Professor at the Cleveland Medical Center, United States- Department of Plastic Surgery
-
Visiting Professor at Seoul Asan Medical Center, Korea-Department of Plastic surgery
-
Guest Attendee at the 101th AAPS meeting (American association of plastic surgeons) in Chicago, 2023
-
President of the Zhejiang Provincial Physician Association Microsurgery Physician Branch
-
Vice President of the Zhejiang Provincial Physician Association Hand Surgery Physician Branch
-
Former Chairman of the Zhejiang Provincial Medical Association Microsurgery Society
-
Vice Chairman of the Zhejiang Provincial Medical Association Hand Surgery Society
-
Chairman of the Zhejiang Rehabilitation Medicine Society Limb Function Reconstruction Professional Committee
-
Vice Chairman of the Chinese Society for Reconstructive and Restorative Surgery Small Joint Group
-
Chairman of the East China Microsurgery Alliance
These positions cover leadership and managerial roles in medical associations and academic groups, indicating that the doctor possesses extensive expertise and experience in fields such as microsurgery, hand surgery, rehabilitation medicine, and reconstructive surgery. Additionally, Prof Qingping Xie holds a certain level of influence and standing in the medical community both domestically and internationally.
About Hangzhou qiushi hosptial
Hangzhou Qiushi Hospital is a leading private, multidisciplinary hospital pioneering research in geriatric diseases including deep cervical LVA supermicrosurgical methods for brain functional disorders such as Alzheimer's disease, Parkinson's disease, tinnitus, and amyotrophic lateral sclerosis (ALS). They are keen to academic collaboration with renowned international and domestic partners in the field of surgical treatment for brain functional disorders.